INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

24,511 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
SP
Sharma PoojaChief Strat/Marketing Officer
PRCTPROCEPT BioRobotics Corp
Open-market sale
SELL$93K
4,710 sh
Nov 6, 2026Nov 6, 2026
Page 8 of 613
← PrevNext →
traded Nov 6, 2026
+0d
SEC Form 4

Evidence

24
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Open-market sale
SELL$166K
50 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

24
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Open-market sale
SELL$218K
66 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

23
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$7.70M
81.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

23
AJ
An JingChief Financial Officer
LKNCYLuckin Coffee Inc.
Open-market sale
SELL$344K
10.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

23
DJ
Dash JeffreyEVP, Business Development
VIKViking Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$2.26M
25.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
HR
Harvey RoryExecutive Vice President
GMGeneral Motors Co
Open-market sale · 10b5-1 plan
SELL$1.48M
16.5K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Open-market sale · 10b5-1 plan
SELL$114K
2,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
AF
AJB Investment Fund II, LP10% Owner
JCTCJEWETT CAMERON TRADING CO LTD
Open-market purchase
BUY$5,640
2,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

22
AF
AJB Investment Fund II, LP10% Owner
JCTCJEWETT CAMERON TRADING CO LTD
Open-market purchase
BUY$2,850
1,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

22
SE
Steele ElisaDirector
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$231K
3,337 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
AF
AJB Investment Fund II, LP10% Owner
JCTCJEWETT CAMERON TRADING CO LTD
Open-market purchase
BUY$4,677
1,641 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

22
AF
AJB Investment Fund II, LP10% Owner
JCTCJEWETT CAMERON TRADING CO LTD
Open-market purchase
BUY$2,095
735 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

22
Saba Capital Management, L.P.10% Owner
DSMBNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.
Open-market purchase
BUY$555
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

22
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$38K
163 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
AF
AJB Investment Fund II, LP10% Owner
JCTCJEWETT CAMERON TRADING CO LTD
Open-market purchase
BUY$5,443
1,930 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
AF
AJB Investment Fund II, LP10% Owner
JCTCJEWETT CAMERON TRADING CO LTD
Open-market purchase
BUY$200
70 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
LW
Liu Dennis W.Chief Accounting Officer
YOUClear Secure, Inc.
Open-market sale · 10b5-1 plan
SELL$87K
1,403 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
CR
Corbin Charles R. Jr.See Remarks
HGVHilton Grand Vacations Inc.
Open-market sale · 10b5-1 plan
SELL$1.78M
40.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
PA
Pisetsky Michael A.SVP, Ops & Adm/Chief Legal Ofr
SIBNSI-BONE, Inc.
Open-market sale · 10b5-1 plan
SELL$899K
36.2K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
AF
AJB Investment Fund II, LP10% Owner
JCTCJEWETT CAMERON TRADING CO LTD
Open-market purchase
BUY$573
201 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

22
EM
Ehrlichman MattDirector, CEO, CHAIRMAN AND FOUNDER, 10% Owner
PRCHPorch Group, Inc.
Open-market sale · 10b5-1 plan
SELL$392K
19.5K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

22
LW
Liu Dennis W.Chief Accounting Officer
YOUClear Secure, Inc.
Open-market sale · 10b5-1 plan
SELL$122K
2,104 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

21
MD
Moradi DavidDirector, EXECUTIVE CHAIRMAN AND CPO, 10% Owner
AEYEAUDIOEYE INC
Open-market sale
SELL$20K
1,464 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

21
EM
Eizen Joshua MSee Remarks
ANTXAN2 Therapeutics, Inc.
Open-market sale
SELL$12K
2,826 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

21
ZC
Zeff Capital, LP10% Owner
BUKSBUTLER NATIONAL CORP
Open-market sale
SELL$29K
5,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

21
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Open-market sale
SELL$9,900
3 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
Saba Capital Management, L.P.10% Owner
ECATBlackRock ESG Capital Allocation Term Trust
Open-market sale
SELL$466K
35.4K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

20
Saba Capital Management, L.P.10% Owner
PDXPIMCO Dynamic Income Strategy Fund
Open-market sale
SELL$678K
32.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
GJ
Gowans JasonEVP and CDTO
LEVILEVI STRAUSS & CO
Open-market sale
SELL$83K
3,494 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
DN
Debbi NirDirector, President
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$4.46M
100.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence